Yale Center for X-Linked Hypophosphatemia

 

 

 

PAST SPEAKERS

Thursday, April 16, 2009

Michael A. Levine, MD, FAAP, FACP, FACE
Division Chief of Endocrinology/Diabetes
The Children's Hospital of Philadelphia

"Gcm2: Master gene for parathyroid development"

 

Thursday, March 19, 2009

John S. Adams, M.D.
Vice Chair for Research
Department of Orthopaedic Surgery
UCLA-Orthopaedic Hospital
Los Angeles, CA

"Vitamin D and estrogen action in bone:
A concerted role for hnRNPs in the C family"

Thursday, October 16, 2008

Michael Collins, M.D.
Craniofacial and Skeletal Diseases Branch
National Institute of Dental and Craniofacial Research, NIH
Bethesda, Maryland

"New insights into the action and regulation of FGF23"

Thursday, April 10, 2008

Andrew C. Karaplis, Ph.D.
Jewish General Hospital
Department of Medicine, Section of Metabolic Bone Disease
McGill University
Montreal, Quebec, Canada

“Parathyroid hormone: An elusive phosphatonin?”

Thursday, October 18, 2007

Lynda Bonewald, Ph.D.
Curators’ Professor & Professor of Oral Biology
Director, Bone Biology Research Program
University of Missouri-Kansas City

“The role of osteocyte in mineral homeostasis”

Thursday, April 12, 2007

Takashi Shimada, Ph.D.
    Research Scientist, Nephrology Group
          Pharmaceutical Research Laboratory, Nephrology
              Kirin Brewery Company, Ltd, Takasaki, Gunma, Japan

"The Roles of FGF23 in Hypophosphatemia"

Thursday, February 15, 2007

Derek LeRoith, M.D., Ph.D.
Professor of Medicine, Chief, Division of Endocrinology &
Diabetes, Department of Medicine, Mt. Sinai School of Medicine

"Using gene knockout models to study the effects of
IGF-1 and IGF binding proteins on bone formation."